Navigation Links
Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
Date:10/3/2007

UNION CITY, Calif., Oct. 3 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood chemistry analysis systems, announced today the launch of the Kidney Check Panel to be used in conjunction with the Piccolo xpress(TM) point of care analyzer.

The new Kidney Check Panel was designed specifically for imaging and radiology centers in the United States to determine the level of renal insufficiency prior to the injection of contrast agents for MRI procedures. This panel contains Creatinine (CRE) and Urea Nitrogen (BUN). As a result of prior FDA clearance on these two analytes, the Kidney Check Panel is released as a CLIA-waived panel.

"Many contrast mediums currently used during an MRI procedure in the outpatient setting can have an adverse effect on the kidneys. The ability to check kidney function prior to and in some cases post MRI, enables the radiologist to rapidly assess the risk level of each patient. In recent months, the FDA has released black box warnings on some of these gadolinium-based contrast agents," stated Dr. Dennis Bleile, Director of Assay Performance and Compliance for Abaxis, Inc.

"The Kidney Check Panel provides a critical solution for the rapid, on-site classification and triaging of MRI patients," commented Rick Betts, Abaxis' Director of Marketing. "We believe this latest CLIA-waived offering answers a significant need for the imaging and radiology market by providing a simple, fast and accurate chemistry solution for on-site kidney function analysis. We also believe the Kidney Check Panel will help increase the efficiency and reduce the risks for our imaging and radiology center customers."

About Abaxis, Inc.

'/>"/>
SOURCE Abaxis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...swire-USNewswire/ -- The American Heart,Associatio... Lewis,Achievement Award, the association,s highes...ard was established in 2000, to recognize and hono...edical journalists who have documented,the conside...ease and,stroke. This career achievement award was...
(Date:7/23/2008)...23 /PRNewswire-USNewswire/ -- The Alameda County,P...ly 24-26 at the Oakland,Marriott to address the so...in individuals from low-income and communities of ...s and counties will attend. Place Matters,is a nat... and Economic,Studies, Health Policy Institute and...
(Date:7/23/2008)...e Dangerous for Morbidly Obese Women? ,As the ...are consulting plastic surgeons for breast reducti...ad been thought to have higher complication rates....e as safe to perform large-volume breast reduction...Study title: Breast Reduction: Safe in the Morbidl...
(Date:7/23/2008)...23 /PRNewswire-USNewswire/ -- The New Jersey,Hospi...t Safety has,received a planning grant for $199,50...o develop a proposal for improving the quality of,...termine over the next six months whether New,Jerse... Quality initiative,which is focused on lifting t...
Breaking Medicine News(10 mins):Health News:Alameda County Hosts National Initiative to Reduce Health Disparities 2
...ason some adolescents experience depression could ...d nearly 30 adolescents between ages 13 to 18, hal...disorder. Magnetic resonance imaging was performed...ft and right hippocampus. The results indicated th...
...and women, 60 to 96 years old, who suffered from l...sarcopenia.// The individuals trained for eight to... strength ranging from 113 percent to 174 percent....uscle loss by incorporating a weight training rout...
...u fat. In an editorial published in the Jan. 10 is...hwestern University researchers stress the need //...ty in the United States by studying how loss of sl...ys that control appetite, food intake and energy e...
...ng been associated with cancers, fibrosis and othe...searchers say // exposure to asbestos may lay the ...rheumatoid arthritis and multiple sclerosis. Resea..., which is known to be polluted by asbestos. They ...
Other Medicine News:Health News:Sleeping Less May be related to Weight Gain 2
(Date:7/23/2008)...de BioPharmaceutics, Inc.,an emerging biopharmace...esults demonstrating the utility of their lead dru...ronic blood disorder paroxysmal nocturnal,hemoglob...ed at the XXII,International Complement Workshop i...ly treatment currently available for PNH patients ...
(Date:7/23/2008)...rotein Therapeutics that Modulate Altern...ss., July 23 /- Taligen Therapeutics ...growth plan with the,appointment of Abbie Celniker...ishment of its headquarters in Cambridge, Mass. Dr...nder of the company who remains president., Under...
(Date:7/22/2008)...er 293-patient European, trial -, http://www.cr... MONTREAL, July 22 / CryoCa...therapy products to treat cardiac,arrhythmias, tod...m three,European study centers using the Company,s...lier today in the Journal of the American College ...
(Date:7/22/2008)...t Initiative bring MJFF,s,current active industry ...09, NEW YORK, July 22 /PRNewswire-USNewswire/ -- ...ormative treatments and a cure for Parkinson,s,dis...s Research has awarded,$2.7 million in total fundi... granted under MJFF,s Therapeutics Development Ini...
Breaking Medicine Technology:InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Vaginal progesterone gel may improve infant outcomes and 2659 1Vaginal progesterone gel may improve infant outcomes and 2659 2Vaginal progesterone gel may improve infant outcomes and 2659 3Vaginal progesterone gel may improve infant outcomes and 2659 4Study Supports Change to Prostate Cancer Biopsy 2657 1Study Supports Change to Prostate Cancer Biopsy 2657 2Study Supports Change to Prostate Cancer Biopsy 2657 3Angel Flight West Recognizes Colorado Pilots and Supporters at AFW 24th Anniversary Awards 2655 1Angel Flight West Recognizes Colorado Pilots and Supporters at AFW 24th Anniversary Awards 2655 2Study Determines Breast Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 2652 1Study Determines Breast Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 2652 2Study Determines Breast Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 2652 3
...I Pharma, Inc.,(Nasdaq:MOGN), a biopharmaceutical ...provided highlights of data presentations made,dur... (ASCO) Annual,Meeting. Dacogen (decitabine) for I... the presentation of efficacy data in older,patien...ity,observed in patients with refractory acute lym...
...2007 - Synta,Pharmaceuticals Corp., (NASDAQ: SNTA)...g, developing, and commercializing small,molecule ...nounced,it will hold a conference call at 2:30 p.m... be presented at the annual meeting of the,America...Illinois,this morning., The conference call will b...
Other Medicine Technology:MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 10
BD Vacutainer® Fluoride Tubes - Glass
BD Vacutainer® Specialty Tubes - Trace Element - Glass
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients.
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology.
Medicine Products: